BusinessAlder BioPharmaceuticals® to Present at 29th Annual Piper Jaffray Healthcare ConferenceBy Nasdaq OMXNov 22, 2017, 1:00 PM UTC
BusinessDepomed to Participate at the Annual Piper Jaffray Healthcare ConferenceBy Nasdaq OMXNov 21, 2017, 9:05 PM UTC
BusinessCatalyst Pharmaceuticals Announces Phase 2 Study of Firdapse® in Ambulatory Patients with Spinal Muscular Atrophy (SMA)By Nasdaq OMXNov 21, 2017, 1:03 PM UTC
BusinessUptick Network “Stock Day” Interviews New HealthWarehouse CEO Joseph Peters on Company Success in 2017By Nasdaq OMXNov 21, 2017, 1:01 PM UTC
BusinessNewLink Genetics Announces the Presentation of Indoximod Data in Phase 1 Study for ChildrenBy Nasdaq OMXNov 20, 2017, 9:25 PM UTC
BusinessSentia Medical Sciences Inc. Announces the Launch of a New Initiative in Stress-related Disorders Targeting Gastrointestinal and Endocrine DiseasesBy Nasdaq OMXNov 17, 2017, 8:01 AM UTC
BusinessArbutus’ LNP Licensee Alnylam Initiates Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for PatisiranBy Nasdaq OMXNov 16, 2017, 6:40 PM UTC
BusinessRafael Pharmaceuticals, in Collaboration with Atlantic Health System, Announces Initiation of a Phase I Study of CPI-613 in Combination with Gemcitabine and Nab-Paclitaxel for Patients with Locally Advanced or Metastatic Pancreatic CancerBy Nasdaq OMXNov 16, 2017, 2:24 PM UTC
